Equities analysts expect BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) to report sales of $515.44 million for the current quarter, Zacks reports. Ten analysts have issued estimates for BioMarin Pharmaceutical’s earnings, with the lowest sales estimate coming in at $495.84 million and the highest estimate coming in at $545.45 million. BioMarin Pharmaceutical reported sales of […]
J.W. Cole Advisors Inc. cut its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 39.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,950 shares of the biotechnology company’s stock after selling 1,950 shares during the quarter. J.W. Cole Advisors Inc.’s […]
Treasurer of the State of North Carolina Buys 1,909 Shares of BioMarin Pharmaceutical Inc (NASDAQ:BMRN) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Shell Asset Management Co Sells 13,784 Shares of BioMarin Pharmaceutical Inc (NASDAQ:BMRN) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.